Delta Diagnostics was founded in 2018 as a spin-off from TNO – The Netherlands Organisation for Applied Scientific Research. It will commercialize the patented  biosensor technology that has been developed at TNO over the last 5 years.

Delta Diagnostics envisions a world in which biomolecular interactions and biomarker concentrations can be measured at low-cost and at any location. Rapid, multiplexed, sensitive and inexpensive biosensors will advance both life-science R&D and point-of-care diagnostics.

We believe that life-sciences will advance dramatically and new discoveries will be made at an much higher rate if the study of biomolecular interactions becomes affordable.

We also believe that the availability of our rapid, sensitive and low-cost biosensors and instruments will lead to new point-of-care diagnostic tests that will rely on the accurate concentration measurement of a panel of biomarkers within minutes.

Delta Diagnostics focusses on developing optical sensors and instruments and will partner with for instance assay developers to co-develop specific applications. If you are interested to work with us please do not hesitate to contact us at